The 2024 Outlook For Global Pharma: A Look Ahead
The industry must brace for further pushback from lawmakers, regulators, and other stakeholders who, emboldened by the IRA victory, continue to try to rein in big pharma.
Stay updated with breaking news from Commercial Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The industry must brace for further pushback from lawmakers, regulators, and other stakeholders who, emboldened by the IRA victory, continue to try to rein in big pharma.
The pharma landscape is more volatile than ever before, and pushback on drug prices will continue to intensify from payers, PBMs and especially consumers.
It's clear that the push by policymakers to rein in the pharmaceutical industry through regulations that force lower drug prices shows no signs of slowing.
Meet the new Miss Teen Earth SA, Chloé-Jade Christian who is already dominating runways in New York City. Find out more about her mission.
While many manufacturers are adapting, new research reveals resistance and challenges as they navigate the "new normal."